Effect of Long-Term Treatment with Fimasartan on Transient Focal Ischemia in Rat Brain

Chi Kyung Kim, Xiu Li Yang, Young Ju Kim, In Young Choi, Han Gil Jeong, Hong Kyun Park, Dohoung Kim, Tae Jung Kim, Hyunduk Jang, Sang Bae Ko, Byung Woo Yoon

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


Fimasartan is a newly developed angiotensin receptor blocker, which may have protective effects during myocardial infarction or atherosclerosis. In this context, we investigated the effects of long-term treatment with low-dose fimasartan on focal ischemia in rat brain. We induced focal ischemia in brain by transient intraluminal occlusion of middle cerebral artery (MCA) and administered low-dose (0.5 mg/kg) or regular doses (1 or 3 mg/kg) of fimasartan via intravenous routes. After the administration of low-dose (0.5 mg/kg) fimasartan, blood pressure did not decrease compared to the phosphate-buffered saline- (PBS-) control with MCA occlusion (MCAO) group. The infarct volume and ischemic cell death were reduced in the low-dose fimasartan-treated group (46 ± 41 mm3 for 0.5 mg/kg and 153 ± 47 mm3 for PBS-control with MCAO; P < 0.01) but not in the regular-dose groups. Low-dose fimasartan treatment improved functional recovery after ischemia and significantly decreased mortality. In our study, fimasartan reduced the degradation of IB and the formation of an inflammatory end-product, COX-2. As a result, the recruitment of inflammatory cells in the peri-infarct area decreased in fimasartan-treated group. We have demonstrated that long-term, low-dose fimasartan treatment improved outcomes after focal ischemia in the brain via a reduction of inflammation.

Original languageEnglish
Article number295925
JournalBioMed Research International
Publication statusPublished - 2015

Bibliographical note

Publisher Copyright:
© 2015 Chi Kyung Kim et al.

ASJC Scopus subject areas

  • General Biochemistry,Genetics and Molecular Biology
  • General Immunology and Microbiology


Dive into the research topics of 'Effect of Long-Term Treatment with Fimasartan on Transient Focal Ischemia in Rat Brain'. Together they form a unique fingerprint.

Cite this